Stonebrook Private’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$331K Buy
+436
New +$329K 0.05% 230
2026
Q1
– Sell
-436
Closed -$331K – 338
2025
Q4
$331K Buy
+436
New +$296K 0.05% 230

Other funds holding REGN

Stonebrook Private's REGN Position: Q3 2026 in Review

Stonebrook Private opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 436 shares worth $331K. The stake represents 0.05% of the portfolio and ranks #230 among its holdings. This is a return to the name: Stonebrook Private previously reported a position in REGN as recently as Q4 2025.

Stonebrook Private first reported a position in REGN in Q4 2025 and has held it in 2 quarters since. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Stonebrook Private held 436 shares of Regeneron Pharmaceuticals worth $331K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Stonebrook Private position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.05% of Stonebrook Private's portfolio in Q3 2026, its #230 holding.
  • Stonebrook Private first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Stonebrook Private's 13F filing for Q3 2026, filed 20 Nov 2026.